Ian Morrison

发表

Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland

S. Chandran, M. Connor, S. Colville, 2020, Journal of Neurology.

Genotype–phenotype characterisation of long survivors with motor neuron disease in Scotland

I. Deary, S. Chandran, J. Prendergast, 2022, Journal of Neurology.

Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study

D. Werring, L. Zambreanu, A. Coles, 2021, The Lancet.

The immediate impact of the COVID-19 pandemic on motor neuron disease services and mortality in Scotland

S. Chandran, M. Connor, S. Pal, 2020, Journal of Neurology.

Theme 11 Cognitive and psychological assessment and support

S. Chandran, M. C. Carboncini, S. Abrahams, 2018, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective

M. Macleod, S. Chandran, J. Chataway, 2021, Brain communications.

Theme 5 Epidemiology and informatics

A. Al-Chalabi, S. Chandran, L. Ossher, 2018, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Clinical audit research and evaluation of motor neuron disease (CARE-MND): a national electronic platform for prospective, longitudinal monitoring of MND in Scotland

S. Chandran, S. Abrahams, S. Colville, 2019, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Motor Neuron Disease is not clustered or associated with socioeconomic deprivation in Scotland.

S. Chandran, M. Connor, S. Pal, 2022, medRxiv.

Genotypes and phenotypes of motor neuron disease: an update of the genetic landscape in Scotland

S. Pal, J. Newton, G. Gorrie, 2024, Journal of neurology.